Cita APA

Tarragó, D., González, I., & González-Escribano, M. F. (2022). HLA-E restricted cytomegalovirus UL40 peptide polymorphism may represent a risk factor following congenital infection.

Citación estilo Chicago

Tarragó, David, Irene González, y María Francisca González-Escribano. HLA-E Restricted Cytomegalovirus UL40 Peptide Polymorphism May Represent a Risk Factor Following Congenital Infection. 2022.

Cita MLA

Tarragó, David, Irene González, y María Francisca González-Escribano. HLA-E Restricted Cytomegalovirus UL40 Peptide Polymorphism May Represent a Risk Factor Following Congenital Infection. 2022.